DOCK4 promotes loss of proliferation in glioblastoma progenitor cells through nuclear beta-catenin accumulation and subsequent miR-302-367 cluster expression

Ionizing radiations sustain glioblastoma cell dedifferentiation to a stem-like phenotype through survivin: possible involvement in radioresistance

(2014) P Dahan et al.   Cell Death & Disease

Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics

(2013) A. Sottoriva et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Tumorigenic Potential of miR-18A* in Glioma Initiating Cells Requires NOTCH-1 Signaling

(2013) Laurent Turchi et al.   STEM CELLS

Single-Molecule Genomic Data Delineate Patient-Specific Tumor Profiles and Cancer Stem Cell Organization

(2012) A. Sottoriva et al.   CANCER RESEARCH

FoxM1 and Wnt/ -Catenin Signaling in Glioma Stem Cells

(2012) A. Gong et al.   CANCER RESEARCH

Targeting β-catenin in CML: Leukemia Stem Cells Beware!

(2012) Maria Kleppe et al.   Cell Stem Cell

Molecular mechanisms of temozolomide resistance in glioblastoma multiforme

(2012) Tor-Christian Aase Johannessen et al.   Expert Review of Anticancer Therapy

Prognostic Impact of the Cancer Stem Cell–Related Marker NANOG in Ovarian Serous Carcinoma

(2012) Maria Lee et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

Small Molecule Antagonists of the Wnt/Beta-Catenin Signaling Pathway Target Breast Tumor-Initiating Cells in a Her2/Neu Mouse Model of Breast Cancer

(2012) Robin M. Hallett et al.   PLoS One

Prognostic significance of NANOG and KLF4 for breast cancer

(2012) Takuya Nagata et al.   Breast Cancer

Adamantyl Retinoid-Related Molecules Induce Apoptosis in Pancreatic Cancer Cells by Inhibiting IGF-1R and Wnt/β-Catenin Pathways

(2012) Lulu Farhana et al.   Journal of Oncology

Mosaic Amplification of Multiple Receptor Tyrosine Kinase Genes in Glioblastoma

(2011) Matija Snuderl et al.   CANCER CELL

The miR 302-367 cluster drastically affects self-renewal and infiltration properties of glioma-initiating cells through CXCR4 repression and consequent disruption of the SHH-GLI-NANOG network

(2011) M Fareh et al.   CELL DEATH AND DIFFERENTIATION

Emerging Roles of Glycogen Synthase Kinase 3 in the Treatment of Brain Tumors

(2011) Caroline N. Mills et al.   Frontiers in Molecular Neuroscience

CD133, CD15/SSEA-1, CD34 or side populations do not resume tumor-initiating properties of long-term cultured cancer stem cells from human malignant glio-neuronal tumors

(2010) Cristina Patru et al.   BMC CANCER

Over-expression of Nanog predicts tumor progression and poor prognosis in colorectal cancer

(2010) Hui-Min Meng et al.   CANCER BIOLOGY & THERAPY

Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1

(2010) Roel G.W. Verhaak et al.   CANCER CELL

Primary brain tumors, neural stem cell, and brain tumor cancer cells: Where is the link?

(2010) Isabelle Germano et al.   NEUROPHARMACOLOGY

Allelic Selection of Amplicons in Glioblastoma Revealed by Combining Somatic and Germline Analysis

(2010) Thomas LaFramboise et al.   PLoS Genetics

GSK3β Regulates Differentiation and Growth Arrest in Glioblastoma

(2009) Serdar Korur et al.   PLoS One

Glycogen Synthase Kinase-3 Inhibition Induces Glioma Cell Death through c-MYC, Nuclear Factor- B, and Glucose Regulation

(2008) S. Kotliarova et al.   CANCER RESEARCH

Malignant Gliomas in Adults

(2008) Patrick Y. Wen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Molecular association between β-catenin degradation complex and Rac guanine exchange factor DOCK4 is essential for Wnt/β-catenin signaling

(2008) G Upadhyay et al.   ONCOGENE